Securing the future of drug discovery for central nervous system disorders

被引：0

作者：

机构：

[1] Innovation Fund Denmark,Department of Psychiatry and Medical Research Council and the Wellcome Trust Behavioural and Clinical Neuroscience Institute

[2] US Food and Drug Administration,undefined

[3] University of Cambridge,undefined

[4] McGill University,undefined

[5] Duke University,undefined

[6] and Dean of Duke-NUS Graduate Medical School,undefined

[7] 8 College Road,undefined

[8] Singapore 169857.,undefined

[9] Deutsche Bank,undefined

[10] University of British Columbia,undefined

来源：

Nature Reviews Drug Discovery | 2014年 / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, representatives of the 2013 Collegium Internationale Neuro-Psychopharmacologicum (CINP) Summit group summarize plans to achieve this goal.

引用

页码：871 / 872

页数：1